Abstract:While electrophilic reagents for
histidine labeling have been developed,
we report an umpolung strategy for histidine functionalization. A
nucleophilic small molecule, 1-methyl-4-arylurazole, selectively labeled
histidine under singlet oxygen (1O2) generation
conditions. Rapid histidine labeling can be applied for instant protein
labeling. Utilizing the short diffusion distance of 1O2 and a technique to localize the 1O2 generator, a photocatalyst in close proximity to the ligand-binding
site, we demonstrated a… Show more
“…Chemoselective modification of this residue is challenging due to the presence of more nucleophilic groups on proteins that can outcompete the imidazole ring for substitutions and to the absence of a particular reactive feature of this aromatic ring that could be used to label it selectively—such as phenols’ facile generation of C -centred radicals, or indoles' high molar absorptivity and propensity to undergo photoionization, for example. Consequently, general, broadly applicable strategies for histidine modifications have regularly showed chemoselectivity issues [ 263 ], circumscribing site-selective reactions to only a few examples.…”
The bioconjugation of proteins—that is, the creation of a covalent link between a protein and any other molecule—has been studied for decades, partly because of the numerous applications of protein conjugates, but also due to the technical challenge it represents. Indeed, proteins possess inner physico-chemical properties—they are sensitive and polynucleophilic macromolecules—that make them complex substrates in conjugation reactions. This complexity arises from the mild conditions imposed by their sensitivity but also from selectivity issues,
viz
the precise control of the conjugation site on the protein. After decades of research, strategies and reagents have been developed to address two aspects of this selectivity: chemoselectivity—harnessing the reacting chemical functionality—and site-selectivity—controlling the reacting amino acid residue—most notably thanks to the participation of synthetic chemistry in this effort. This review offers an overview of these chemical bioconjugation strategies, insisting on those employing native proteins as substrates, and shows that the field is active and exciting, especially for synthetic chemists seeking new challenges.
“…Chemoselective modification of this residue is challenging due to the presence of more nucleophilic groups on proteins that can outcompete the imidazole ring for substitutions and to the absence of a particular reactive feature of this aromatic ring that could be used to label it selectively—such as phenols’ facile generation of C -centred radicals, or indoles' high molar absorptivity and propensity to undergo photoionization, for example. Consequently, general, broadly applicable strategies for histidine modifications have regularly showed chemoselectivity issues [ 263 ], circumscribing site-selective reactions to only a few examples.…”
The bioconjugation of proteins—that is, the creation of a covalent link between a protein and any other molecule—has been studied for decades, partly because of the numerous applications of protein conjugates, but also due to the technical challenge it represents. Indeed, proteins possess inner physico-chemical properties—they are sensitive and polynucleophilic macromolecules—that make them complex substrates in conjugation reactions. This complexity arises from the mild conditions imposed by their sensitivity but also from selectivity issues,
viz
the precise control of the conjugation site on the protein. After decades of research, strategies and reagents have been developed to address two aspects of this selectivity: chemoselectivity—harnessing the reacting chemical functionality—and site-selectivity—controlling the reacting amino acid residue—most notably thanks to the participation of synthetic chemistry in this effort. This review offers an overview of these chemical bioconjugation strategies, insisting on those employing native proteins as substrates, and shows that the field is active and exciting, especially for synthetic chemists seeking new challenges.
“…8A ). 51 In the presence of a 1-methyl-4-arylurazole nucleophile 52, the oxidized His intermediate is trapped, leading to a C5 conjugated product 53. This strategy was exemplified by labeling peptides and antibodies with azide handles for fluorescent tagging; modifications occurred rapidly (∼15 min) at the embedded His residues under biocompatible conditions.…”
Section: Umpolung Strategies For the Functionalization Of Amino Acid ...mentioning
confidence: 99%
“…It is envisaged that the efficiency of this approach may also allow for the extension of the strategy to intracellular applications. 51 Notably, this His labeling strategy does not maintain the imidazole structure in the conjugated product 53. This method therefore represents a non-classical umpolung approach as the majority of umpolung strategies preserve the primary structural features of the starting amino acids in their conjugated products.…”
Section: Umpolung Strategies For the Functionalization Of Amino Acid ...mentioning
confidence: 99%
“…The latter approach has recently been explored by Sato and co-workers for labeling at the C5 position of the imidazole ring in peptides and proteins. 51 This strategy was inspired by prior reports which identified His–His, His–Cys and His–Lys cross-linked side chains in the analytical analyses of monoclonal antibodies that were attributed to a photooxidative cross-linking mechanism. 52 Capitalizing on this pathway, the His labeling approach was developed through the photocatalytic generation of singlet oxygen, which subsequently undergoes a Diels–Alder reaction with the His imidazole side chain to afford an electrophilic endoperoxide intermediate 51 ( Fig.…”
Section: Umpolung Strategies For the Functionalization Of Amino Acid ...mentioning
This perspective highlights the growing body of literature that leverages polarity reversal (umpolung reactivity) for the selective modification of proteinogenic functionalities and identifies opportunities for further innovation.
“…The oxidative dimerization of benzylamine and the phosphonylation reaction from phenylhydrazine [28] were also achieved. Singlet-oxygen-mediated reactions have been studied in synthetic chemistry and chemical biology; [29] hence, this photocatalytic system expands their applications based on the high penetration depth of NIR light. This NIR-reaction system also permits the scalable synthesis with batch reactors, [7b] which requires in industry.…”
Section: Table 5 Penetration Experiments For the Visible-cdc Reaction (Condition A) And The Nir-cdc Reaction (Condition B)mentioning
The high penetration of near-infrared (NIR) light makes it effective for use in selective reactions under lightshielded conditions, such as in sealed reactors and deep tissues. Herein, we report the development of phthalocyanine catalysts directly activated by NIR light to transform small organic molecules. The desired photocatalytic properties were achieved in the phthalocyanines by introducing the appropriate peripheral substituents and central metal. These phthalocyanine photocatalysts promote cross-dehydrogenative-coupling (CDC) under irradiation with 810 nm NIR light.The choice of solvent is important, and a mixture of a reaction-accelerating (pyridine) and -decelerating (methanol) solvents was particularly effective. Moreover, we demonstrate photoreactions under visible-light-shielded conditions through the transmission of NIR light. A combined experimental and computational mechanistic analysis revealed that this NIR reaction does not involve a photoredox-type mechanism with electron transfer, but instead a singletoxygen-mediated mechanism with energy transfer.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.